FibroGen, Inc. (NASDAQ:FGEN) Shares Sold by Price T Rowe Associates Inc. MD
Price T Rowe Associates Inc. MD reduced its position in FibroGen, Inc. (NASDAQ:FGEN – Free Report) by 25.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 116,000 shares of the biopharmaceutical company’s stock after selling 40,500 shares during […]
Price T Rowe Associates Inc. MD reduced its position in FibroGen, Inc. (NASDAQ:FGEN – Free Report) by 25.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 116,000 shares of the biopharmaceutical company’s stock after selling 40,500 shares during […]
